2017-18

Way foreword
• Sales review- Achievement & Future Plan

• Opportunities, Challenges & way foreword

Current brands
New Launches(Pharmaceutical)
INFACARE
 TARGET
NO PRODUCTS UNITS TARGET VALUE UNITS VALUE DEFICIT
1Antimal Syrup 2400 16104 0 0 16104
2Apextite Syrup 3000 23010 0 0 23010
3Cold Naso 10954 28042.24 0 0 28042.24
4Hot Naso 10954 41953.82 0 0 41953.82
5Kamaclox mouthwash 30000 172800 13000 67392 105408
6Kamatrim suspension 4800 12288 0 0 12288
7Major Nasal Drop 8000 40800 30000 137700 -96900
8Omega Oil Liniment 5000 30050 22280 120513 -90462.5
9Tres-Orix Forte 100ml 10000 76700 5000 34515 42185
10Tres-Orix Forte 250ml 80000 1073600 62500 754875 318725
11Liverplex B Infant 2400 8016 8400 39690 -31674
12Liverplex B 200 ml 2400 12600 0 0 12600
13Kamatone syrup 4800 42624 42624
1578588.06 1154685 423903.6
NO PRODUCTS TARGET UNITS TARGET VALUE UNITS VALUE DEFICIT
1Antimal Syrup 2400 16104 0 0 16104
2Apextite Syrup 5000 38350 300 2071 36279
3Cold Naso 10041 25704 5400 12442 13263
4Hot Naso 1041 38456 20400 70319 -31863
5Kamaclox mouthwash 30000 172800 6000 31104 141696
6Kamatrim suspension 0 0 500 1152 -1152
7Major Nasal Drop 8000 40800 43000 197370 -156570
8Omega Oil Liniment 5000 30050 16200 87626 -57576
9Tres-Orix Forte 100ml 10000 76700 2500 17258 59443
10Tres-Orix Forte 250ml 80000 1073600 10000 120780 952820
11Liverplex B Infant 2400 8016 0 0 8016
12Liverplex B 200 ml 4400 23100 13400 63315 -40215
13Kamatone syrup 0 0 0 0 0
1543681 598305 940245
MONTH TGT 2017-18 SALES PROJECTION % OF ACH
July 1578588.06 1154685 73
Aug 1543680.712 598305 39
Sept 1488619.56 1650000 111
Oct 1420755.56 1000000 70
Nov 1110092.56 1300000 117
Dec 758013.56 800000 106
Jan 1139211.136 1300000 114
Feb 1296325.426 1400000 108
March 1114047.136 1450000 130
April 1150964.272 1450000 126
May 872885.002 1200000 137
June 784350.272 1000000 127
14257533.26 14302990 100
Existing SKUs- Opportunities-

The market of Ghana is highly potential and

competitive. The existing brands has a good
market except Antimal because of the decline
of quinine market to (alpha beta arteether).
• Challenges –
• We already had a base of around 700k to 800k Ghana Cedies in the
beginning. Earlier MIKADDO had a big sales team(7 medical reps and 15
sales reps) and had done various marketing activities to reach the
consumers through TV/Radio adverts and other kind of
promotions(Posters/Standies/Promotional gifts to pharmacies).

• Here the Ghanian market is majorly driven by adverts and Dr/Pharmacy

prescription.

• We have to start meeting Drs for promotion or have to do other marketing

activities including Radio/TV adverts.(Average cost of a prime time TV Add
ranges from 30k to 50k Ghana cedis per month. Average cost of FM radio
adverts expense will be 20k-30k Ghana cedies per month).
 NEW DISTRIBUTOR PLAN
• CURRENTLY OUR DISTRIBUTORSHIP IS MAJORLY WITH ONLY 5 ACTIVE
DISTRIBUTORS WICH WE ARE PLANNING TO REVIVE.
• WE NEED TO OPEN UP THE MARKET ACROSS GHANA TO FETCH MAXIMUM
MARKET AND TO AVOID THE DIPENDANCY ON A FEW.
• WE HAVE ALREADY IDENTIFIED AND ALMOST FINALISED WITH SOME GOOD
PARTIES IN ACCRA.
• PLANNED NEW DISTRIBUTORS IN ACCRA-
1- TOBINCO
2- KELMED
3- ADEPA
4-ASCOT
5- WEDAMA.
• AND WE ARE PLANNING DISTRIBUTORS IN OTHER REGIONS ALSO- PLAN IS
TO APPOINT DISTRIBUTORS IN KUMASI, CAPECOAST AND TAKORADI IN THE
FIRST PHASE AND THEN IN UPPER REGIONS ALSO( TAMALE)
• Betasil Range
• Malidhar L/Inj
• Sep guard gel
• Tolpidol OD
• Podine mouthwash
• Hemolok solution
• GSD powder
• INFACARE
• Infacare is a high potential and challenging brand which needs to be
launched aggressively in the market to grab the market share. We have
met many big firms for convincing them to take the brand in Ghana( both
marketing& Distribution) but nobody shown any interest due to the risk
associated with the brand.

• The best way left for us is to do the promotion by our own and distribution
through our Pharma channels and selected consumer distributors.
• Hospitals,Doctors & Midwives – They are the major points in the
promotion of Infacare.

• Our current manpower doesn’t serve the purpose as it is too small for
even the existing brands-

• We need a separate full-fledged team exclusively for the brand( Minimum

of 7 medical reps)
Plan is to do a minimum business of 40000 tins a
year with a growth of at least 60% per year